Back to Search
STAVROS MANOLAGAS, MD
MD
Internal Medicine Physician
NPI: 1760572242Individual
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
E-0115(AR)
Endocrinology, Diabetes & Metabolism Physician
Internal Medicine — Endocrinology, Diabetes & Metabolism
Code: 207RE0101X
E-0115(AR)
Research & Publications (20)
De-fense! De-fense! De-fense: scavenging H2O2 while making cholesterol.
PMID 18483146·Endocrinology·2008
7-preclinical
Gone with the Wnts: beta-catenin, T-cell factor, forkhead box O, and oxidative stress in age-dependent diseases of bone, lipid, and glucose metabolism.
PMID 17622581·Mol Endocrinol·2007
6-review
Oxidative stress antagonizes Wnt signaling in osteoblast precursors by diverting beta-catenin from T cell factor- to forkhead box O-mediated transcription.
PMID 17623658·J Biol Chem·2007
7-preclinical
Kinase-mediated transcription, activators of nongenotropic estrogen-like signaling (ANGELS), and osteoporosis: a different perspective on the HRT dilemma.
PMID 15461702·Kidney Int Suppl·2004
6-review
Perspective: nonreproductive sites of action of reproductive hormones.
PMID 11356663·Endocrinology·2001
4-observational
Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis.
PMID 10782361·Endocr Rev·2000
6-review
Increased lipid oxidation causes oxidative stress, increased peroxisome proliferator-activated receptor-gamma expression, and diminished pro-osteogenic Wnt signaling in the skeleton.
PMID 19657144·J Biol Chem·2009
7-preclinical
Intermittent PTH stimulates periosteal bone formation by actions on post-mitotic preosteoblasts.
PMID 19010455·Bone·2009
7-preclinical
Giant osteoclast formation and long-term oral bisphosphonate therapy.
PMID 19118304·N Engl J Med·2009
2-rct
Commitment to the osteoblast lineage is not required for RANKL gene expression.
PMID 19279010·J Biol Chem·2009
7-preclinical
Targeted deletion of a distant transcriptional enhancer of the receptor activator of nuclear factor-kappaB ligand gene reduces bone remodeling and increases bone mass.
PMID 17932217·Endocrinology·2008
7-preclinical
Connexin 43 is required for the anti-apoptotic effect of bisphosphonates on osteocytes and osteoblasts in vivo.
PMID 18597631·J Bone Miner Res·2008
7-preclinical
Control of bone mass and remodeling by PTH receptor signaling in osteocytes.
PMID 18698360·PLoS One·2008
7-preclinical
Quantifying osteoblast and osteocyte apoptosis: challenges and rewards.
PMID 17542686·J Bone Miner Res·2007
6-review
Glucocorticoids induce osteocyte apoptosis by blocking focal adhesion kinase-mediated survival. Evidence for inside-out signaling leading to anoikis.
PMID 17581824·J Biol Chem·2007
7-preclinical
A novel ligand-independent function of the estrogen receptor is essential for osteocyte and osteoblast mechanotransduction.
PMID 17609204·J Biol Chem·2007
7-preclinical
Skeletal involution by age-associated oxidative stress and its acceleration by loss of sex steroids.
PMID 17623659·J Biol Chem·2007
7-preclinical
Extracellular matrix made by bone marrow cells facilitates expansion of marrow-derived mesenchymal progenitor cells and prevents their differentiation into osteoblasts.
PMID 17680726·J Bone Miner Res·2007
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 4301 W MARKHAM ST # 783
LITTLE ROCK, AR 72205 - Phone
- (501) 686-8000
Quick Facts
- NPI
- 1760572242
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile